Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype

Francesca Cortini, Chiara Villa, Barbara Marinelli, Sara Franchetti, Manuela Seia, Angela Cecilia Pesatori, Nicola Montano, Alessandra Bassotti

Research output: Contribution to journalArticle

Abstract

Classical Ehlers-Danlos syndrome (cEDS) is a heritable connective tissue disorder (HCTD) characterized by skin hyperelasticity, joint hypermobility and general tissue fragility. Mutations in COL5A1 and COL5A2 genes, encoding the type V collagen proalpha-1 (pro-α1) and proalpha-2 (pro-α2) chains respectively, are responsible of approximately 90% cEDS patients. The molecular basis of cEDS was investigated in a 43-years-old Italian woman by Target Enrichment Approach and variants were confirmed with different method as Sanger Sequencing. The analysis revealed an already described stop-gain mutation c.3769C>T, p. (Arg1257*) (rs748870349) in exon 48 of COL5A1 gene and two additional variants located in exon 48 of COL5A2 gene, that are a novel missense mutation c.3466C>G, p. (Pro1156Ala) and a known variant c.3379C>T, p. (Arg1127Cys) (rs886055354). All mutations were in heterozygous state and located in the triple-helix domain of collagen type V. The combination/co-presence of these three different collagen mutations confirmed the phenotype of EDS patients.

Original languageEnglish
Pages (from-to)132-136
Number of pages5
JournalMeta Gene
Volume18
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Ehlers-Danlos Syndrome
Missense Mutation
Collagen Type V
Phenotype
Mutation
Exons
Genes
Joint Instability
Connective Tissue
Collagen
Skin

Keywords

  • Biochemical Analysis
  • Collagen type V protein
  • Ehlers-Danlos Syndrome Classic type
  • Next Generation Sequencing

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Ehlers-Danlos Syndrome classical type : A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype. / Cortini, Francesca; Villa, Chiara; Marinelli, Barbara; Franchetti, Sara; Seia, Manuela; Pesatori, Angela Cecilia; Montano, Nicola; Bassotti, Alessandra.

In: Meta Gene, Vol. 18, 01.12.2018, p. 132-136.

Research output: Contribution to journalArticle

@article{02d9f58886504850994256bf22f0b288,
title = "Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype",
abstract = "Classical Ehlers-Danlos syndrome (cEDS) is a heritable connective tissue disorder (HCTD) characterized by skin hyperelasticity, joint hypermobility and general tissue fragility. Mutations in COL5A1 and COL5A2 genes, encoding the type V collagen proalpha-1 (pro-α1) and proalpha-2 (pro-α2) chains respectively, are responsible of approximately 90{\%} cEDS patients. The molecular basis of cEDS was investigated in a 43-years-old Italian woman by Target Enrichment Approach and variants were confirmed with different method as Sanger Sequencing. The analysis revealed an already described stop-gain mutation c.3769C>T, p. (Arg1257*) (rs748870349) in exon 48 of COL5A1 gene and two additional variants located in exon 48 of COL5A2 gene, that are a novel missense mutation c.3466C>G, p. (Pro1156Ala) and a known variant c.3379C>T, p. (Arg1127Cys) (rs886055354). All mutations were in heterozygous state and located in the triple-helix domain of collagen type V. The combination/co-presence of these three different collagen mutations confirmed the phenotype of EDS patients.",
keywords = "Biochemical Analysis, Collagen type V protein, Ehlers-Danlos Syndrome Classic type, Next Generation Sequencing",
author = "Francesca Cortini and Chiara Villa and Barbara Marinelli and Sara Franchetti and Manuela Seia and Pesatori, {Angela Cecilia} and Nicola Montano and Alessandra Bassotti",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.mgene.2018.08.012",
language = "English",
volume = "18",
pages = "132--136",
journal = "Meta Gene",
issn = "2214-5400",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Ehlers-Danlos Syndrome classical type

T2 - A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype

AU - Cortini, Francesca

AU - Villa, Chiara

AU - Marinelli, Barbara

AU - Franchetti, Sara

AU - Seia, Manuela

AU - Pesatori, Angela Cecilia

AU - Montano, Nicola

AU - Bassotti, Alessandra

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Classical Ehlers-Danlos syndrome (cEDS) is a heritable connective tissue disorder (HCTD) characterized by skin hyperelasticity, joint hypermobility and general tissue fragility. Mutations in COL5A1 and COL5A2 genes, encoding the type V collagen proalpha-1 (pro-α1) and proalpha-2 (pro-α2) chains respectively, are responsible of approximately 90% cEDS patients. The molecular basis of cEDS was investigated in a 43-years-old Italian woman by Target Enrichment Approach and variants were confirmed with different method as Sanger Sequencing. The analysis revealed an already described stop-gain mutation c.3769C>T, p. (Arg1257*) (rs748870349) in exon 48 of COL5A1 gene and two additional variants located in exon 48 of COL5A2 gene, that are a novel missense mutation c.3466C>G, p. (Pro1156Ala) and a known variant c.3379C>T, p. (Arg1127Cys) (rs886055354). All mutations were in heterozygous state and located in the triple-helix domain of collagen type V. The combination/co-presence of these three different collagen mutations confirmed the phenotype of EDS patients.

AB - Classical Ehlers-Danlos syndrome (cEDS) is a heritable connective tissue disorder (HCTD) characterized by skin hyperelasticity, joint hypermobility and general tissue fragility. Mutations in COL5A1 and COL5A2 genes, encoding the type V collagen proalpha-1 (pro-α1) and proalpha-2 (pro-α2) chains respectively, are responsible of approximately 90% cEDS patients. The molecular basis of cEDS was investigated in a 43-years-old Italian woman by Target Enrichment Approach and variants were confirmed with different method as Sanger Sequencing. The analysis revealed an already described stop-gain mutation c.3769C>T, p. (Arg1257*) (rs748870349) in exon 48 of COL5A1 gene and two additional variants located in exon 48 of COL5A2 gene, that are a novel missense mutation c.3466C>G, p. (Pro1156Ala) and a known variant c.3379C>T, p. (Arg1127Cys) (rs886055354). All mutations were in heterozygous state and located in the triple-helix domain of collagen type V. The combination/co-presence of these three different collagen mutations confirmed the phenotype of EDS patients.

KW - Biochemical Analysis

KW - Collagen type V protein

KW - Ehlers-Danlos Syndrome Classic type

KW - Next Generation Sequencing

UR - http://www.scopus.com/inward/record.url?scp=85052904889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052904889&partnerID=8YFLogxK

U2 - 10.1016/j.mgene.2018.08.012

DO - 10.1016/j.mgene.2018.08.012

M3 - Article

AN - SCOPUS:85052904889

VL - 18

SP - 132

EP - 136

JO - Meta Gene

JF - Meta Gene

SN - 2214-5400

ER -